Core Insights - Meinian Health's stock closed at 5.45 yuan, up 2.06%, with a rolling PE ratio of 72.68, marking a new low in 13 days, and a total market capitalization of 21.333 billion yuan [1] - The average PE ratio for the healthcare services industry is 38.66, with a median of 38.36, placing Meinian Health at 37th in the industry ranking [1] - As of Q1 2025, 50 institutions hold shares in Meinian Health, including 42 funds, with a total holding of 1,662.9292 million shares valued at 9.379 billion yuan [1] Company Overview - Meinian Health's main business is health examination services, with its primary product being health check-up services [1] - The latest performance report for Q1 2025 shows the company achieved operating revenue of 1.754 billion yuan, a year-on-year decrease of 2.62%, and a net profit of -275.338 million yuan, a year-on-year increase of 3.94%, with a gross profit margin of 24.04% [1] Industry Comparison - Meinian Health's PE ratio of 72.68 is significantly higher than the industry average of 38.66 and the median of 38.36 [2] - The industry includes various companies with varying PE ratios, with the highest being -313.36 for RunDa Medical and the lowest at -102.63 for ST Biology [2]
美年健康收盘上涨2.06%,滚动市盈率72.68倍,总市值213.33亿元